Query         021248
Match_columns 315
No_of_seqs    200 out of 671
Neff          5.9 
Searched_HMMs 46136
Date          Fri Mar 29 08:46:17 2013
Command       hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/021248.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/021248hhsearch_cdd -cpu 12 -v 0 

 No Hit                             Prob E-value P-value  Score    SS Cols Query HMM  Template HMM
  1 KOG2778 Ubiquitin C-terminal h 100.0 1.2E-92 2.7E-97  653.6  23.1  293    1-312    20-316 (328)
  2 PF01088 Peptidase_C12:  Ubiqui 100.0 1.9E-64 4.1E-69  459.7  12.7  183    1-189    19-214 (214)
  3 KOG1415 Ubiquitin C-terminal h 100.0 2.6E-60 5.7E-65  420.8  16.9  191    1-203    22-221 (222)
  4 PF07888 CALCOCO1:  Calcium bin  69.5      67  0.0014   33.8  11.9   30  133-167    86-115 (546)
  5 PHA02744 hypothetical protein;  55.9       7 0.00015   31.2   1.5   12  135-146     5-16  (88)
  6 KOG1103 Predicted coiled-coil   26.0 1.6E+02  0.0034   29.6   5.8   36  251-286   144-188 (561)
  7 PF10146 zf-C4H2:  Zinc finger-  24.9 4.9E+02   0.011   24.2   8.7   52  247-298    54-106 (230)
  8 cd08065 MPN_eIF3h Mpr1p, Pad1p  23.8 2.5E+02  0.0054   26.4   6.6   26  255-280   226-255 (266)
  9 PF09726 Macoilin:  Transmembra  23.0 8.2E+02   0.018   26.6  11.0   53  246-298   545-603 (697)
 10 CHL00044 rpl16 ribosomal prote  21.3      80  0.0017   27.0   2.5   22  134-155    88-109 (135)
 11 PHA00447 lysozyme               20.5      88  0.0019   26.8   2.6   20  133-154    41-60  (142)

No 1  
>KOG2778 consensus Ubiquitin C-terminal hydrolase [Posttranslational modification, protein turnover, chaperones]
Probab=100.00  E-value=1.2e-92  Score=653.58  Aligned_cols=293  Identities=66%  Similarity=1.059  Sum_probs=258.2

Q ss_pred             CCCcccEEEEeecCChhhhhccCCceEEEEEeecCCCCccccccccCCCCCccchhhhhhhhhHHHHHHHhhhCCC--CC
Q 021248            1 MQVKGVQVEELYSLDLDSLNNLRPVYGLIFLFKWRPGEKDDRVVIKDPNPNLFFASQVINNACATQAILSILLNCP--DI   78 (315)
Q Consensus         1 lGv~~~~f~DVysLD~~~L~~l~Pv~alIfLFp~~~~~~~~~~~~~~~~~~v~FakQtI~NACgT~AlLh~l~N~~--~i   78 (315)
                      |||+|+||+||||||.+.+..++|||||||||+|.+++++.+....+.-++||||||+|+|||||+|||++|+|+.  +|
T Consensus        20 fgv~gvQVEElysLd~~~~~~~~piyGlIFLFKW~~ed~~~g~v~~D~~~niFFA~QvInNACATqAlLsvLlN~~~~~i   99 (328)
T KOG2778|consen   20 FGVKGVQVEELYSLDSDSLRPLRPIYGLIFLFKWIEEDKPAGSVIDDSVSNIFFAKQVINNACATQALLSVLLNCSHEDI   99 (328)
T ss_pred             cCCCceeEeeeeccCcchhccCCCceeEEEEEEeccCCCCCcccccccccchhhhhhhcccHHHHHHHHHHHHcCCcccc
Confidence            7999999999999999999999999999999999987666655555555689999999999999999999999984  69


Q ss_pred             CCCcchHHHHHHhcCCChhhHHhhhcCCHHHHHHHHhcCCCCCCCccccccCC--CCCCcceEEEEEeeCCeEEeecCCC
Q 021248           79 DIGPELSKLKEFTKNFPPELKGLAINNSDAIRAAHNSFARPEPFVPEEQKAAG--KDDDVYHFISYIPVDGVLYELDGLK  156 (315)
Q Consensus        79 ~lgs~L~~f~~~t~~~~p~~Rg~~L~ns~~i~~~Hns~A~~g~~~~~~~~~~~--~~~~~~HFI~fV~~~G~lyELDGlk  156 (315)
                      +||++|++||+||++|+|+.||.+|+|+++||.+|||||||.++.+++..+..  .++++||||+|||++|+||||||+|
T Consensus       100 dLG~tLs~~K~f~k~f~Pe~KGlal~Nse~Ir~~HNSfARp~~~~~~e~~a~~~~~~dd~yHFVsyvPI~g~lyELDGLk  179 (328)
T KOG2778|consen  100 DLGPTLSELKEFTKGFDPELKGLALGNSEEIRCAHNSFARPEPFRPEEVDAATSAKEDDVYHFVSYVPINGRLYELDGLK  179 (328)
T ss_pred             chhhHHHHHHHHhhcCChhhcccccCCcHHHHHHhccccCCCCcchhhhhcccccccccceeEEEEEeeCCEEEeccCCc
Confidence            99999999999999999999999999999999999999999986654433222  3678999999999999999999999


Q ss_pred             CCCcccCCCCCCCCcccHHHHHHHHHHHHHHhhccCCceeEEEEeecCchHHHHHHHHHHHHHHHHHHHHHhhhhhhhcc
Q 021248          157 EGPISLGPCTGGQGDMDWLQMVQPVIQERIERYSKSEIRFNLMAVIKNRKELYTAELKEFQRKRERILQQLASLQSERMV  236 (315)
Q Consensus       157 ~~Pi~~G~~~~~~~~~~~l~~a~~vi~~ri~~y~~~~i~FslmAL~~d~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~~  236 (315)
                      .|||+||+|..   +++|+++|+|||++||++|++++|||||||||+|++   ..+|..+++.++.|+.++...      
T Consensus       180 e~PI~lg~~~~---eqeW~d~vrpVIqeRi~~ys~gEIrFNLMAvV~dRk---~a~l~~~~~~~e~l~~~l~~~------  247 (328)
T KOG2778|consen  180 EGPIDLGPCEK---EQEWLDKVRPVIQERIQRYSEGEIRFNLMAVVPDRK---TAELKELQRKREILLQQLQKQ------  247 (328)
T ss_pred             cCCcccCCCCc---cHhHHHHHHHHHHHHHhhCCcceeEEEEEEEeccch---HHHHHHHHHHHHHHHHHHHhh------
Confidence            99999999986   269999999999999999999999999999999998   556666777777777766531      


Q ss_pred             cccchhHhhhhHHHHHHhHHHHHHHHHHHHHHHhhhHHHHhcccCCcHHHHHHHHHHHHhcCCchHHHHHHHHhhc
Q 021248          237 DKTSFEALNKSLSEVNAGIEGATEKILMEEEKFKKWRTENIRRKHNYIPFLFNFLKILAEKKQLKPLIEKAKQKTS  312 (315)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~i~~~~~~i~~E~~k~~~~~~En~rRrhny~pfi~~llk~La~~g~L~~l~~~a~~~~~  312 (315)
                             ........+++|+.++..|..|.+|+.+|+.||+||||||.||+++|+|.||++|+|.+++++||.|..
T Consensus       248 -------~~~~~~~~q~~ia~~~~~i~~e~~K~~~~k~en~rr~hny~pfl~ellk~lae~~~L~~~~~kak~~~~  316 (328)
T KOG2778|consen  248 -------EATEADKEQSEIANLSSHIRPEDEKLKRYKKENIRRKHNYLPFLVELLKILAEEGQLAPLVEKAKPKSM  316 (328)
T ss_pred             -------hccchhhhhhhhcccccccCcchhHhhhcchhhhhhhhcccHHHHHHHHHHhhhcchhhhhhhhcchhh
Confidence                   011112256788888889999999999999999999999999999999999999999999999987654


No 2  
>PF01088 Peptidase_C12:  Ubiquitin carboxyl-terminal hydrolase, family 1;  InterPro: IPR001578 In the MEROPS database peptidases and peptidase homologues are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry based on a common structural fold:  Each clan is identified with two letters, the first representing the catalytic type of the families included in the clan (with the letter 'P' being used for a clan containing families of more than one of the catalytic types serine, threonine and cysteine). Some families cannot yet be assigned to clans, and when a formal assignment is required, such a family is described as belonging to clan A-, C-, M-, N-, S-, T- or U-, according to the catalytic type. Some clans are divided into subclans because there is evidence of a very ancient divergence within the clan, for example MA(E), the gluzincins, and MA(M), the metzincins. Peptidase families are grouped by their catalytic type, the first character representing the catalytic type: A, aspartic; C, cysteine; G, glutamic acid; M, metallo; N, asparagine; S, serine; T, threonine; and U, unknown. The serine, threonine and cysteine peptidases utilise the amino acid as a nucleophile and form an acyl intermediate - these peptidases can also readily act as transferases. In the case of aspartic, glutamic and metallopeptidases, the nucleophile is an activated water molecule. In the case of the asparagine endopeptidases, the nucleophile is asparagine and all are self-processing endopeptidases.   In many instances the structural protein fold that characterises the clan or family may have lost its catalytic activity, yet retain its function in protein recognition and binding.  Cysteine peptidases have characteristic molecular topologies, which can be seen not only in their three-dimensional structures, but commonly also in the two-dimensional structures. These are peptidases in which the nucleophile is the sulphydryl group of a cysteine residue. Cysteine proteases are divided into clans (proteins which are evolutionary related), and further sub-divided into families, on the basis of the architecture of their catalytic dyad or triad [].   This group of cysteine peptidases belong to the MEROPS peptidase family C12 (ubiquitin C-terminal hydrolase family, clan CA). Families within the CA clan are loosely termed papain-like as protein fold of the peptidase unit resembles that of papain, the type example for clan CA. The type example is the human ubiquitin C-terminal hydrolase UCH-L1. Ubiquitin is highly conserved, commonly found conjugated to proteins in eukaryotic cells, where it may act as a marker for rapid degradation, or it may have a chaperone function in protein assembly []. The ubiquitin is released by cleavage from the bound protein by a protease []. A number of deubiquitinising proteases are known: all are activated by thiol compounds [, ], and inhibited by thiol-blocking agents and ubiquitin aldehyde [, ], and as such have the properties of cysteine proteases []. The deubiquitinsing proteases can be split into 2 size ranges (20-30 kDa and 100-200 kDa, IPR001394 from INTERPRO) []: this family are the 20-30 kDa ppeptides which includes the yeast yuh1. Yeast yuh1 protease is known to be active only against small ubiquitin conjugates, being inactive against conjugated beta-galactosidase []. A mammalian homologue, UCH (ubiquitin conjugate hydrolase), is one of the most abundant proteins in the brain []. Only one conserved cysteine can be identified, along with two conserved histidines. The spacing between the cysteine and the second histidine is thought to be more representative of the cysteine/histidine spacing of a cysteine protease catalytic dyad [].; GO: 0004221 ubiquitin thiolesterase activity, 0006511 ubiquitin-dependent protein catabolic process, 0005622 intracellular; PDB: 1CMX_A 4DM9_A 2ETL_A 3IRT_A 3KW5_A 3IFW_A 2LEN_A 3KVF_A 2WDT_C 2WE6_B ....
Probab=100.00  E-value=1.9e-64  Score=459.73  Aligned_cols=183  Identities=51%  Similarity=0.884  Sum_probs=154.9

Q ss_pred             CCCcccEEEEeecCCh-hhhhcc-CCceEEEEEeecCCCCcccc------cc--ccCCCCCccchhhhhhhhhHHHHHHH
Q 021248            1 MQVKGVQVEELYSLDL-DSLNNL-RPVYGLIFLFKWRPGEKDDR------VV--IKDPNPNLFFASQVINNACATQAILS   70 (315)
Q Consensus         1 lGv~~~~f~DVysLD~-~~L~~l-~Pv~alIfLFp~~~~~~~~~------~~--~~~~~~~v~FakQtI~NACgT~AlLh   70 (315)
                      |||++++|+||||||+ ++|+++ +|||||||||||++..+..+      ..  ....+++|||+||||+||||||||||
T Consensus        19 lGv~~~~f~Dv~sld~~~lL~~ip~Pv~alI~lfp~~~~~~~~~~~~~~~~~~~~~~~~~~v~f~kQti~NACgt~AlLh   98 (214)
T PF01088_consen   19 LGVSGVQFEDVYSLDDPELLAMIPRPVYALIFLFPWTEEYEERRAEEDAKIEEKGQDIPENVFFAKQTIGNACGTIALLH   98 (214)
T ss_dssp             TTBTSEEEEEESTSSHHHHHTTSSSSEEEEEEEEE--HHHHHHHHHHHHHHCCHSCTCGTTS-EES-SSBTGHHHHHHHH
T ss_pred             cCCceeEEEEcccccchHhhhhcCccceeEEEEEecchhhhhhhccccccccccccCCCCCceEeeecCCchhhHHHHHH
Confidence            7999999999999999 459999 99999999999996432211      11  12345689999999999999999999


Q ss_pred             hhhCCCC---CCCCcchHHHHHHhcCCChhhHHhhhcCCHHHHHHHHhcCCCCCCCccccccCCCCCCcceEEEEEeeCC
Q 021248           71 ILLNCPD---IDIGPELSKLKEFTKNFPPELKGLAINNSDAIRAAHNSFARPEPFVPEEQKAAGKDDDVYHFISYIPVDG  147 (315)
Q Consensus        71 ~l~N~~~---i~lgs~L~~f~~~t~~~~p~~Rg~~L~ns~~i~~~Hns~A~~g~~~~~~~~~~~~~~~~~HFI~fV~~~G  147 (315)
                      +|+|+++   |.+||.|++|+++|.+|+|++||.+|++++.|+.+||+||++|++..+.  ...+++++||||||||++|
T Consensus        99 ~l~N~~~~~~i~~gs~L~~f~~~t~~~~p~~Rg~~l~~~~~l~~aH~s~A~~g~t~~~~--~~~~~~~~~HFI~fV~~~G  176 (214)
T PF01088_consen   99 ALLNNPDRIEIEPGSILDQFKEFTKDLSPEERGKALENSKELRKAHNSFARQGQTEAPD--DEADDEVDFHFIAFVPVDG  176 (214)
T ss_dssp             HHHTCCCTTCBBTTSHHHHHHHHHTTSTHHHHHHHHHTHHHHHHHHHHHHCHCSSTS-H----TTSCGCEEEEEEEEETT
T ss_pred             HHhcccccccccCCchHHHHHHHHhcCCHHHHHHHHhCcHHHHHHHHHHhccCCcCCCc--cccCCCCCccEEEEEeECC
Confidence            9999987   8889999999999999999999999999999999999999999865321  1135667899999999999


Q ss_pred             eEEeecCCCCCCcccCCCCCCCCcccHHHHHHHHHHHHHHhh
Q 021248          148 VLYELDGLKEGPISLGPCTGGQGDMDWLQMVQPVIQERIERY  189 (315)
Q Consensus       148 ~lyELDGlk~~Pi~~G~~~~~~~~~~~l~~a~~vi~~ri~~y  189 (315)
                      +||||||||+|||+||++++    ++|+++|+++|++||++|
T Consensus       177 ~LyELDG~k~~Pi~~G~~~~----~~~l~~a~~vik~~m~~y  214 (214)
T PF01088_consen  177 HLYELDGRKSGPIDHGPCSD----EDWLSDARPVIKERMERY  214 (214)
T ss_dssp             EEEEEETTSSS-EEEEE-BT----TSHHHHHHHHHHHHHHHH
T ss_pred             eEEEcCCCCCCCeEcCcCCC----ccHHHHHHHHHHHHHhcC
Confidence            99999999999999999985    899999999999999998


No 3  
>KOG1415 consensus Ubiquitin C-terminal hydrolase UCHL1 [Posttranslational modification, protein turnover, chaperones]
Probab=100.00  E-value=2.6e-60  Score=420.82  Aligned_cols=191  Identities=36%  Similarity=0.539  Sum_probs=172.0

Q ss_pred             CCCcc-cEEEEeecCChhhhhcc-CCceEEEEEeecCCCCcccccc----ccCCCCCccchhhhhhhhhHHHHHHHhhhC
Q 021248            1 MQVKG-VQVEELYSLDLDSLNNL-RPVYGLIFLFKWRPGEKDDRVV----IKDPNPNLFFASQVINNACATQAILSILLN   74 (315)
Q Consensus         1 lGv~~-~~f~DVysLD~~~L~~l-~Pv~alIfLFp~~~~~~~~~~~----~~~~~~~v~FakQtI~NACgT~AlLh~l~N   74 (315)
                      |||++ |+|.||||||++.|+++ |||+|||||||+++..+..+..    .++.+++||||||||+|||||+||||+|+|
T Consensus        22 lGv~~~~~~~DVy~ldee~L~~vPrPv~A~lllFP~~e~~e~~~~~~~e~~k~~~~~V~fmkQti~NACGTiaLlHslaN  101 (222)
T KOG1415|consen   22 LGVAGEWSVVDVYGLDEESLEFVPRPVKALLLLFPITEKREEFRKEQIEEIKEQSDKVFFMKQTIGNACGTIALLHSLAN  101 (222)
T ss_pred             hCCCCceEEEEeeecChhhhhhcCccceEEEEEecccchhhHhhhhhHhhhhcCCCceEEEeccccchhHHHHHHHHHhc
Confidence            79998 99999999999999999 9999999999999754433211    123356899999999999999999999999


Q ss_pred             CCC---CCCCcchHHHHHHhcCCChhhHHhhhcCCHHHHHHHHhcCCCCCCCccccccCCCCCCcceEEEEEeeCCeEEe
Q 021248           75 CPD---IDIGPELSKLKEFTKNFPPELKGLAINNSDAIRAAHNSFARPEPFVPEEQKAAGKDDDVYHFISYIPVDGVLYE  151 (315)
Q Consensus        75 ~~~---i~lgs~L~~f~~~t~~~~p~~Rg~~L~ns~~i~~~Hns~A~~g~~~~~~~~~~~~~~~~~HFI~fV~~~G~lyE  151 (315)
                      +.+   +..||.|++|++.+.+|+|++|+++|+++++|+.+|..+|..|++.       .++++++||||||.+||+|||
T Consensus       102 ~~~r~~l~~Gs~l~~fl~~~~~~s~eeRa~~le~d~~l~~~H~a~a~eGqte-------~~~~vd~HFI~~v~~~G~lYE  174 (222)
T KOG1415|consen  102 NEDRVKLEDGSFLKKFLEEAEKMSPEERADLLENDEELEAAHEAAAQEGQTE-------ADEDVDLHFICFVNKNGHLYE  174 (222)
T ss_pred             cccccccCCchHHHHHHHHhhcCCHHHHHHHhcccHHHHHHHHHHHhcCCCC-------CccccceEEEEEEccCCeEEE
Confidence            987   5669999999999999999999999999999999999999999863       235678999999999999999


Q ss_pred             ecCCCCCCcccCCCCCCCCcccHHHHHHHHHHHHHHhhccCCceeEEEEeec
Q 021248          152 LDGLKEGPISLGPCTGGQGDMDWLQMVQPVIQERIERYSKSEIRFNLMAVIK  203 (315)
Q Consensus       152 LDGlk~~Pi~~G~~~~~~~~~~~l~~a~~vi~~ri~~y~~~~i~FslmAL~~  203 (315)
                      ||||++|||.||++++    +.++.+|.+||+++|++ .+++++||+|||++
T Consensus       175 LDgR~~fPi~hG~ts~----~tl~kda~~v~k~~~~~-~~nel~Fs~iAl~~  221 (222)
T KOG1415|consen  175 LDGRKPFPINHGPTSD----DTLLKDAAKVCKEFIER-NPNELRFSAIALTK  221 (222)
T ss_pred             ecCCcCCCccCCCCch----HHHHHHHHHHHHHHHHc-CCCccceEEEEecC
Confidence            9999999999999986    78999999999999999 57889999999986


No 4  
>PF07888 CALCOCO1:  Calcium binding and coiled-coil domain (CALCOCO1) like;  InterPro: IPR012852 Proteins found in this family are similar to the coiled-coil transcriptional coactivator protein expressed by Mus musculus (CoCoA, Q8CGU1 from SWISSPROT). This protein binds to a highly conserved N-terminal domain of p160 coactivators, such as GRIP1 (Q61026 from SWISSPROT), and thus enhances transcriptional activation by a number of nuclear receptors. CoCoA has a central coiled-coil region with three leucine zipper motifs, which is required for its interaction with GRIP1 and may regulate the autonomous transcriptional activation activity of the C-terminal region []. 
Probab=69.53  E-value=67  Score=33.78  Aligned_cols=30  Identities=27%  Similarity=0.589  Sum_probs=20.7

Q ss_pred             CCCcceEEEEEeeCCeEEeecCCCCCCcccCCCCC
Q 021248          133 DDDVYHFISYIPVDGVLYELDGLKEGPISLGPCTG  167 (315)
Q Consensus       133 ~~~~~HFI~fV~~~G~lyELDGlk~~Pi~~G~~~~  167 (315)
                      ++.-|.| |||-..|.|.   | ...|...++..+
T Consensus        86 ~~e~Yqf-cYv~~~g~V~---G-~S~pFqf~~~~p  115 (546)
T PF07888_consen   86 DDEFYQF-CYVDQKGEVR---G-ASTPFQFRAPKP  115 (546)
T ss_pred             CCCeEEE-EEECCCccEE---E-ecCCcccCCCCc
Confidence            3456888 9999999875   3 455666665444


No 5  
>PHA02744 hypothetical protein; Provisional
Probab=55.95  E-value=7  Score=31.25  Aligned_cols=12  Identities=33%  Similarity=0.791  Sum_probs=10.0

Q ss_pred             CcceEEEEEeeC
Q 021248          135 DVYHFISYIPVD  146 (315)
Q Consensus       135 ~~~HFI~fV~~~  146 (315)
                      .-||||||||..
T Consensus         5 ~~~~y~CiVPkE   16 (88)
T PHA02744          5 GKYHYICIAPKE   16 (88)
T ss_pred             CceeEEEEecHH
Confidence            359999999965


No 6  
>KOG1103 consensus Predicted coiled-coil protein [Function unknown]
Probab=26.05  E-value=1.6e+02  Score=29.59  Aligned_cols=36  Identities=22%  Similarity=0.316  Sum_probs=20.7

Q ss_pred             HHHhHHHHHHHHHHHHHHHh---------hhHHHHhcccCCcHHH
Q 021248          251 VNAGIEGATEKILMEEEKFK---------KWRTENIRRKHNYIPF  286 (315)
Q Consensus       251 ~~~~i~~~~~~i~~E~~k~~---------~~~~En~rRrhny~pf  286 (315)
                      ++.+-.+++.+|+-|.+..+         .-..|+.+.||.-+..
T Consensus       144 LEKEReqL~QQiEFe~~e~kK~E~~k~Kl~~qLeeEk~RHeqis~  188 (561)
T KOG1103|consen  144 LEKEREQLQQQIEFEIEEKKKAEIAKDKLEMQLEEEKKRHEQISL  188 (561)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            44555556666654443222         2246788999986654


No 7  
>PF10146 zf-C4H2:  Zinc finger-containing protein ;  InterPro: IPR018482 Zinc finger (Znf) domains are relatively small protein motifs which contain multiple finger-like protrusions that make tandem contacts with their target molecule. Some of these domains bind zinc, but many do not; instead binding other metals such as iron, or no metal at all. For example, some family members form salt bridges to stabilise the finger-like folds. They were first identified as a DNA-binding motif in transcription factor TFIIIA from Xenopus laevis (African clawed frog), however they are now recognised to bind DNA, RNA, protein and/or lipid substrates [, , , , ]. Their binding properties depend on the amino acid sequence of the finger domains and of the linker between fingers, as well as on the higher-order structures and the number of fingers. Znf domains are often found in clusters, where fingers can have different binding specificities. There are many superfamilies of Znf motifs, varying in both sequence and structure. They display considerable versatility in binding modes, even between members of the same class (e.g. some bind DNA, others protein), suggesting that Znf motifs are stable scaffolds that have evolved specialised functions. For example, Znf-containing proteins function in gene transcription, translation, mRNA trafficking, cytoskeleton organisation, epithelial development, cell adhesion, protein folding, chromatin remodelling and zinc sensing, to name but a few []. Zinc-binding motifs are stable structures, and they rarely undergo conformational changes upon binding their target.  This entry represents a family of proteins which appears to have a highly conserved zinc finger domain at the C-terminal end, described as -C-X2-CH-X3-H-X5-C-X2-C-. The structure is predicted to contain a coiled coil. Members of this family are annotated as being tumour-associated antigen HCA127 in humans, but this could not be confirmed.
Probab=24.94  E-value=4.9e+02  Score=24.22  Aligned_cols=52  Identities=19%  Similarity=0.181  Sum_probs=31.4

Q ss_pred             hHHHHHHhHHHHHHHHHHHHHHHhhhHHHHhcccCCcHHHHHHHHHHHHh-cC
Q 021248          247 SLSEVNAGIEGATEKILMEEEKFKKWRTENIRRKHNYIPFLFNFLKILAE-KK  298 (315)
Q Consensus       247 ~~~~~~~~i~~~~~~i~~E~~k~~~~~~En~rRrhny~pfi~~llk~La~-~g  298 (315)
                      .|..+..+|..+...|..-+..+.+-.....|.-+.|.|+-.+.=+++.+ -|
T Consensus        54 eLrqI~~DIn~lE~iIkqa~~er~~~~~~i~r~~eey~~Lk~~in~~R~e~lg  106 (230)
T PF10146_consen   54 ELRQINQDINTLENIIKQAESERNKRQEKIQRLYEEYKPLKDEINELRKEYLG  106 (230)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence            44456677777777775544444444444455556788877666555555 44


No 8  
>cd08065 MPN_eIF3h Mpr1p, Pad1p N-terminal (MPN) domains without catalytic isopeptidase activity, found in eIF2h. Eukaryotic translation initiation factor 3 (eIF3) subunit h (eIF3h; eIF3 subunit 3; eIF3S3; eIF3-gamma; eIF3-p40) is an evolutionarily non-conserved subunit of the functional core that comprises eIF3a, eIF3b, eIF3c, eIF3e, eIF3f, and eIF3h, and contains the MPN domain. However, it lacks the canonical JAMM motif, and therefore does not show catalytic isopeptidase activity.Together with eIF3e and eIF3f, eIF3h stabilizes the eIF3 complex. Results suggest that eIF3h regulates cell growth and viability, and that over-expression of the gene may provide growth advantage to prostate, breast, and liver cancer cells. For example, EIF3h gene amplification is common in late-stage prostate cancer suggesting that it may be functionally involved in the progression of the disease. It has been shown that coamplification of MYC, a well characterized oncogene involved in cell growth, different
Probab=23.84  E-value=2.5e+02  Score=26.44  Aligned_cols=26  Identities=15%  Similarity=0.478  Sum_probs=18.0

Q ss_pred             HHHHHHHHHHHHHHHhhh----HHHHhccc
Q 021248          255 IEGATEKILMEEEKFKKW----RTENIRRK  280 (315)
Q Consensus       255 i~~~~~~i~~E~~k~~~~----~~En~rRr  280 (315)
                      ....+..+..|..+..+|    +.||+.|+
T Consensus       226 ~~~y~r~~~~~~~~~~~~~~kr~~en~~r~  255 (266)
T cd08065         226 FNYYQRNLARQQAQIQQWLQKRKAENAQRE  255 (266)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHhHHHH
Confidence            334577788888887777    57886554


No 9  
>PF09726 Macoilin:  Transmembrane protein;  InterPro: IPR019130  This entry represents the multi-pass transmembrane protein Macoilin, which is highly conserved in eukaryotes. ; GO: 0016021 integral to membrane
Probab=23.03  E-value=8.2e+02  Score=26.64  Aligned_cols=53  Identities=15%  Similarity=0.255  Sum_probs=31.0

Q ss_pred             hhHHHHHHhHHHHHHHHHHHHHHHhhhHHHH-hccc-----CCcHHHHHHHHHHHHhcC
Q 021248          246 KSLSEVNAGIEGATEKILMEEEKFKKWRTEN-IRRK-----HNYIPFLFNFLKILAEKK  298 (315)
Q Consensus       246 ~~~~~~~~~i~~~~~~i~~E~~k~~~~~~En-~rRr-----hny~pfi~~llk~La~~g  298 (315)
                      .-..+++.|+.+|+..+..-++....+..|. ..|.     +.=.-.++..|..|-+|.
T Consensus       545 ~r~~~lE~E~~~lr~elk~kee~~~~~e~~~~~lr~~~~e~~~~~e~L~~aL~amqdk~  603 (697)
T PF09726_consen  545 QRRRQLESELKKLRRELKQKEEQIRELESELQELRKYEKESEKDTEVLMSALSAMQDKN  603 (697)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHHHH
Confidence            3344567777777777765555555566655 1222     334556666677666554


No 10 
>CHL00044 rpl16 ribosomal protein L16
Probab=21.33  E-value=80  Score=27.01  Aligned_cols=22  Identities=18%  Similarity=0.459  Sum_probs=19.5

Q ss_pred             CCcceEEEEEeeCCeEEeecCC
Q 021248          134 DDVYHFISYIPVDGVLYELDGL  155 (315)
Q Consensus       134 ~~~~HFI~fV~~~G~lyELDGl  155 (315)
                      ....|+||.|+.+--|+|++|.
T Consensus        88 G~~~~~va~V~~G~ilfEi~g~  109 (135)
T CHL00044         88 GSPEYWVAVVKPGRILYEMGGV  109 (135)
T ss_pred             CCccEEEEEECCCcEEEEEeCC
Confidence            3468999999999999999984


No 11 
>PHA00447 lysozyme
Probab=20.45  E-value=88  Score=26.76  Aligned_cols=20  Identities=45%  Similarity=0.469  Sum_probs=15.5

Q ss_pred             CCCcceEEEEEeeCCeEEeecC
Q 021248          133 DDDVYHFISYIPVDGVLYELDG  154 (315)
Q Consensus       133 ~~~~~HFI~fV~~~G~lyELDG  154 (315)
                      .+..|||+  |-.||.|||.-|
T Consensus        41 ~dIgYhf~--I~~dG~I~eGR~   60 (142)
T PHA00447         41 LDVGYHFI--IRRDGTVEEGRP   60 (142)
T ss_pred             CCcCeEEE--ECCCCEEEECCC
Confidence            35689994  688999999544


Done!